MAPLELANE CAPITAL, LLC - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 468 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2015. The put-call ratio across all filers is 0.90 and the average weighting 1.0%.

Quarter-by-quarter ownership
MAPLELANE CAPITAL, LLC ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q4 2015$11,114,000
+1843.0%
120,001
-11.8%
0.59%
+1623.5%
Q3 2015$572,000136,1010.03%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q4 2015
NameSharesValueWeighting ↓
Capital Analysts, LLC 7,350$439,309,0000.18%
GOLDMAN SACHS GROUP INC 2,996,127$179,078,0000.07%
MUFG Americas Holdings Corp 52,285$3,125,0000.06%
Zurcher Kantonalbank (Zurich Cantonalbank) 22,936$1,367,0000.05%
GOLDMAN SACHS GROUP INC 419,100$25,050,0000.01%
AQR Capital Management 35,829$2,141,0000.01%
HSBC HOLDINGS PLC 33,669$2,009,0000.01%
GOLDMAN SACHS GROUP INC 147,000$8,786,0000.00%
NOMURA HOLDINGS INC 6,000$359,0000.00%
Twin Tree Management, LP 455$27,0000.00%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders